The Liquid Biopsy and Tumor Progression in Breast Cancer
111 – 120 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
AIB1 is a new putative prognostic biomarker in the luminal A and B-like (HER2-negative) classification of invasive lobular carcinoma
Narbe, Ulrik LU ; Forsare, Carina LU
; Bendahl, Pär-Ola
LU
; Lövgren, Kristina
LU
; Alkner, Sara
LU
; Sjöström, Martin
LU
; Ryden, Lisa
LU
; Leeb-Lundberg, Fredrik
LU
; Ingvar, Christian
LU
and Fernö, Mårten
LU
(2017)
San Antonio Breast Cancer Symposium, 2017
p.1-07
- Contribution to conference › Abstract
-
Mark
Quality of up to 35 years old archival breast cancer tissue in paraffin-blocks for estrogen receptor evaluation
Ehinger, Anna LU
; Ryden, Lisa
LU
; Bendahl, Pär-Ola
LU
; Fernö, Mårten
LU
and Alkner, Sara
LU
(2017)
29th European Congress of Pathology
In Virchows Archiv
471.
- Contribution to journal › Published meeting abstract
- 2016
-
Mark
St Gallen molecular subtypes in screening-detected and symptomatic breast cancer in a prospective cohort with long-term follow-up.
Falck, Anna-Karin LU ; Röme, Andrada LU ; Fernö, Mårten LU ; Olsson, H ; Chebil, G ; Bendahl, Pär-Ola LU and Rydén, Lisa LU
(2016)
In British Journal of Surgery
103(5).
p.513-523
- Contribution to journal › Article
-
Mark
A FISH-based method for assessment of HER-2 amplification status in breast cancer circulating tumor cells following CellSearch isolation
Frithiof, Henrik LU ; Aaltonen, Kristina LU
and Rydén, Lisa
LU
(2016)
In OncoTargets and Therapy
2016(9).
p.7095-7103
- Contribution to journal › Article
-
Mark
Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort
Jansson, Sara LU ; Bendahl, Pär Ola LU ; Larsson, Anna Maria LU ; Aaltonen, Kristina E. LU
and Rydén, Lisa
LU
(2016)
In BMC Cancer
16(1).
- Contribution to journal › Article
-
Mark
Two years of adjuvant tamoxifen provides a survival benefit compared with no systemic treatment in premenopausal patients with primary breast cancer : Long-Term follow-up (> 25 years) of the phase III SBII:2pre trial
Ekholm, Maria LU ; Bendahl, Pär Ola LU ; Fernö, Mårten LU ; Nordenskjöld, Bo ; Stål, Olle and Rydén, Lisa LU
(2016)
In Journal of Clinical Oncology
34(19).
p.2232-2238
- Contribution to journal › Article
- 2015
-
Mark
A novel method for downstream characterization of breast cancer circulating tumor cells following CellSearch isolation.
Frithiof, Henrik LU ; Welinder, Charlotte LU ; Larsson, Anna-Maria LU ; Rydén, Lisa LU
and Aaltonen, Kristina
LU
(2015)
In Journal of Translational Medicine
13(1).
- Contribution to journal › Article
-
Mark
Systemic Monocytic-MDSCs Are Generated from Monocytes and Correlate with Disease Progression in Breast Cancer Patients.
Bergenfelz, Caroline LU
; Larsson, Anna-Maria
LU
; von Stedingk, Kristoffer
LU
; Gruvberger, Sofia
LU
; Aaltonen, Kristina
LU
; Jansson, Sara
LU
; Jernström, Helena
LU
; Janols, Helena
LU
; Wullt, Marlene
LU
and Bredberg, Anders
LU
, et al.
(2015)
In PLoS ONE
10(5).
- Contribution to journal › Article
-
Mark
TURBT Can Cause Seeding of Cancer Cells into the Bloodstream.
Engilbertsson, Helgi LU ; Aaltonen, Kristina LU
; Björnsson, Steinarr
LU
; Kristmundsson, Thorarinn
LU
; Hultman Patschan, Oliver
LU
; Rydén, Lisa
LU
and Gudjonsson, Sigurdur
LU
(2015)
In Journal of Urology
193(1).
p.53-57
- Contribution to journal › Article
-
Mark
Gene expression of breast cancer related genes in circulating tumour cells (CTCs) from patients with metastatic breast cancer
Aaltonen, K. E. LU
; Graffman, C.
LU
; Larsson, A. M.
LU
and Rydén, L.
LU
(2015)
In Annals of Oncology
26(Suppl. 3).
p.15-15
- Contribution to journal › Article